°Q½×°Ï>¤ß®®¥ÍÂå
Åý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O
·|­û:²q·Q 10136148 µoªí®É¶¡:2017/8/21 ¤U¤È 05:20:28
§N¼ö´`Àô , ¬O¥|©uªº¥²µM

º¦¶^¥æ´À , ¬OªÑ¥«ªº°¸µM

¶}³o­Óª©¤D¦³·P©ó

Cliff¤j®¦¼w¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡zªº±M·~½×­z

Åý¤p§Ìµo¨¥®É , ²`©È·\¹ï¤j®aªºµ§°O

¤]©È§j½K¤@´ò¬K¤ô , ¯}Ãa¤j®aªY½à±M·~ªº¬ü·P

©Ò¥H , ³o­Óª©

¤£¥u 543 ¥i¥H½Í 1234567890abcdef ¤]Åwªï

§Æ±æ¼ö¾x¬O­ì«h

¥»ª©¬O¦h¨¥°ó ¦h¤è¬Ý¨Æ ¦h±¡¹ï«Ý

¬ß±æ

¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡z¬O§Ú­Ìªº¦@¦Pµ§°O

¡yÅý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O¡z«h¬OÄÝ©ó¤j®aªº¦@¦P¤é°O

´Á«Ý±zªº°Ñ»P

ÁÂÁ¤j®a!

·|­û:²q·Q10136148µoªí®É¶¡:2019/1/1 ¤U¤È 10:21:13²Ä1073½g¦^À³
SyneuRx Neuroscience

SYNEURX LIFESCIENCE

·|­û:seniorbbs10144999µoªí®É¶¡:2019/1/1 ¤W¤È 10:43:03²Ä1072½g¦^À³
¤j®a¯u¬O²H©w.....

¦p¦¹¬Ý¨ÓÀ³¸Ó¬O±ÂÅv¤è­±½Íªº¤w¸g®t¤£¦h¤F......

¦~©³¼W¸êªº¤è¦¡­ì¨Ó¬O±ÂÅv

¤£ª¾¹D³o¼Ë¸ÑŪ¦³µL¿ù»~..........

·|­û:¤p³ì10135960µoªí®É¶¡:2018/12/31 ¤U¤È 06:27:32²Ä1071½g¦^À³
§Ç¸¹ 4 µo¨¥¤é´Á 107/12/31 µo¨¥®É¶¡ 16:36:59

µo¨¥¤H «¸§Ó¿« µo¨¥¤H¾ºÙ °ÆÁ`¸g²z µo¨¥¤H¹q¸Ü 02-77422699

¥D¦®

¤½§i¥»¤½¥q¸³¨Æ·|¨Mij108¦~²Ä¤@¦¸ªÑªFÁ{®É·|¥l¶}¨Æ©y

²Å¦X±ø´Ú ¡@²Ä 32 ´Ú ¨Æ¹êµo¥Í¤é 107/12/31

»¡©ú

1.¸³¨Æ·|¨Mij¤é´Á:107/12/31

2.ªÑªFÁ{®É·|¥l¶}¤é´Á:108/02/27

3.ªÑªFÁ{®É·|¥l¶}¦aÂI:·s¥_¥«¦Á¤î°Ï·s¥x¤­¸ô¤@¬q97¸¹4¼Ó(B´É»·¶¯U-Town±µ«Ý¤¤¤ß)

4.¥l¶°¨Æ¥Ñ:

(¤@)°Q½×¨Æ¶µ

(1)¸Ñ°£¸³¨ÆÄv·~­­¨î®×

(2)±ÂÅv¸³¨Æ·|ñ­q±M§QÅv±ÂÅv®×

(¤G)Á{®É°Êij

(¤T)´²·|

5.°±¤î¹L¤á°_©l¤é´Á:108/01/29

6.°±¤î¹L¤áºI¤î¤é´Á:108/02/27

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL

·|­û:¤p³ì10135960µoªí®É¶¡:2018/12/31 ¤U¤È 06:23:27²Ä1070½g¦^À³
3 µo¨¥¤é´Á 107/12/31 µo¨¥®É¶¡ 16:36:39

µo¨¥¤H «¸§Ó¿« µo¨¥¤H¾ºÙ °ÆÁ`¸g²z µo¨¥¤H¹q¸Ü 02-77422699

¥D¦®

¤½§i¥»¤½¥q¸³¨Æ·|¨Mij´£½ÐªÑªF·|±ÂÅv»P

SyneuRx Neuroscienceñ­q±M§QÅv±ÂÅv«´¬ù

²Å¦X±ø´Ú ¡@²Ä 43 ´Ú ¨Æ¹êµo¥Í¤é 107/12/31

»¡©ú

1.¨Æ¹êµo¥Í¤é:107/12/31

2.¤½¥q¦WºÙ:SyneuRx Neuroscience

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):SyneuRx Neuroscience¤½¥q¬°¥»¤½¥qÃö«Y¥ø·~

¤§¥S§Ì¤½¥q¡A­t³d¤H§d¶®¬Â¤k¤h¬°¥»¤½¥q¸³¨Æªø¤§°t°¸¡C

4.¬Û¤¬«ùªÑ¤ñ¨Ò(­Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î

5.µo¥Í½t¥Ñ:¥»¤½¥q¸³¨Æ·|¨Mij¡A¬°¥[±j¸ó°êÀç¹B¡A´£½ÐªÑªF·|±ÂÅv¥»¤½¥q»PÃö«Y¥ø·~

SyneuRx Neuroscienceñ­q±M§Q±ÂÅv«´¬ù¡A±ÂÅv©Ò¦³¶W¯Å¥é»sÃĤÎÁ{§É¹êÅç¤G/¤T´Á

¬ãµoÃĪ«¬ÛÃö±M§Q(Programs in supergenerics and phases II/III pipeline) ¡C

¥BSyneuRx Neuroscience¥Ñ¥»¤½¥q±ÂÅv±M§Q¶µ¥Ø©Ò¨ú±o¤§¦¬¯q¡A¦©°£¦æ¬F¶O¥Î¤§«á¡A

±N¥þ¼Æªð¦^¥»¤½¥q¡C

6.¦]À³±¹¬I:µL

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:

(1)¥»®×¯A¤ÎÃö«Y¤H¥æ©ö¡A±ÂÅv«´¬ù«Ý¥»¤½¥qªÑªFÁ{®É·|³q¹L«á¤è¥Í®Ä¡C

·|­û:¤p©¯¹B10141538µoªí®É¶¡:2018/12/27 ¤W¤È 10:38:44²Ä1069½g¦^À³
Study Type : Interventional (Clinical Trial)

Estimated Enrollment : 348 participants

Allocation: Randomized

Intervention Model: Parallel Assignment

Masking: Double (Participant, Investigator)

Primary Purpose: Treatment

Official Title: An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (DAAO Inhibitor), as an Add-on Treatment for Schizophrenia in Adults

Actual Study Start Date : March 29, 2017

Estimated Primary Completion Date : December 31, 2018

Estimated Study Completion Date : June 30, 2019

-----------------------------------------------------------------------------------------------

¨Ì·Ó¹w­p§¹¦¨¤éEstimated Primary Completion Date : December 31, 2018

´Á¬ßªñ´Á¤½¥q´£¨Ñ³Ì·s·sÃĶi«×¸ê°T...

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/25 ¤W¤È 10:09:23²Ä1068½g¦^À³
¤Æ¦Xª«Åé¥~¿z¿ï¸ÕÅ礤­«­n«ü¼Ð¤¶²Ð

¨Ó·½¡GÃÄ´ç ¡@2018-12-25

med.sina.com/article_detail_103_2_58059.html

. ¿z¿ïªºÃþ«¬

. ¿@«×-ÅTÀ³¦±½u©MIC50

. ¡§±`¼Æ¡¨Ãþ«ü¼Ð: Kd ¡BKi¡BKB¡BKA¡BKm

. ³Ì¤jµ²¦X¦ìÂI¼ÆBmax

. ¥b³Ì¤j®Ä¯à¿@«×»P®Ä¯à¡GEC50 & Emax

. ¿E°Ê¾¯¡B³¡¤À¿E°Ê¾¯¡B«ú§Ü¾¯¡BÅܺc½Õ¸`¾¯¥H¤Î¤Ï¦V¿E°Ê¾¯

. Àx³Æ¨üÅé

. Á`µ²

¤Æ¦Xª«ªºÅé¥~¿z¿ï¬OÃĪ«¶}µo³Ì°_©l¤]¬O«D±`­«­nªº¤@­Ó¶¥¬q¡A¡§ÅªÀ´¡¨´ú¸Õ¼Æ¾Ú¬O¨Mµ¦ªº°ò¥»±ø¥ó¡A¥u¦³¦U­Ó«ü¼Ð¦b¤@­Ó¦X²zªº°Ï¶¡¤º¤~¨ã¦³¶i¦æ¶i¤@¨BÀu¤Æªº»ù­È¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/25 ¤W¤È 10:04:33²Ä1067½g¦^À³
¼w¶Ô2018³Ì·s¼Æ¾Ú¡G¤W¥«¤@­Ó·sÃÄ»Ý22»õ¬ü¤¸¦^³ø²v³Ð¾ú¥v·s§C

¨Ó·½¡GÂåÃÄÅ]¤è ¡@2018-12-25

med.sina.com/article_detail_103_2_58054.html

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/25 ¤W¤È 10:04:33²Ä1066½g¦^À³
¼w¶Ô2018³Ì·s¼Æ¾Ú¡G¤W¥«¤@­Ó·sÃÄ»Ý22»õ¬ü¤¸¦^³ø²v³Ð¾ú¥v·s§C

¨Ó·½¡GÂåÃÄÅ]¤è ¡@2018-12-25

med.sina.com/article_detail_103_2_58054.html

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/20 ¤U¤È 06:31:58²Ä1065½g¦^À³
Scientists create genomic resource to explore biological underpinnings of brain disorders

Date:

December 13, 2018

Source:

University of North Carolina Health Care

www.sciencedaily.com/releases/2018/12/181213142112.htm

Won¤Î¨ä¦P¨Æªí©ú¡A³o¨Ç°ò¦]·|¼vÅT¥ý«eºë¯«¤Àµõ¯g¬ã¨s¤¤¯A¤Îªº¬ðIJ¡A¤A酰ÁxÆP¨üÅé¡AÂ÷¤l³q¹D©M¨ä¥L³~®|ªº¥\¯à¡C

¬ì¾Ç®a­ÌÁÙ½T©w¡Aºë¯«¤Àµõ¯g¥D­n¬O¯«¸g¤¸¯e¯f¡A¦Ó¤£¬O¨ä¥L¸£²Ó­M¡C( The scientists also determined that schizophrenia is primarily a disorder of neurons, not of other brain cells. )

en.wikipedia.org/wiki/Neuron

½²±Ð±Â±M¤å

Glutamatergic mechanisms in schizophrenia

¦¨¬°SND-11 ~ SND-13 ¾÷Â઺²z½×°ò¦

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/20 ¤W¤È 10:59:56²Ä1064½g¦^À³
¤ß®®Äw¸êªº¤è¦¡

1.¼W¸ê

2.IPO

3.±ÂÅv

·íµM¥H±ÂÅv¤è¦¡³Ì¨ü¥«³õÅwªï

FDAµ¹ªºBTD ¬JµM¤£¯à§l¤Þ¥xÆW¥«³õªº²´¥ú , ´N¥u¦³¾a¤j¼tªº¼z²´¤F

µL²á¤§¨¥

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/13 ¤W¤È 10:06:01²Ä1063½g¦^À³
§¨Ó¦A½äªüº¸¯ý®üÀq¯f 20»õ¬ü¤¸¦X§@¶}µo¤@´ÚÁ{§É«eTau³J¥Õ¹v¦VÃĪ«

¨Ó·½¡GÂåÃÄÅ]¤è ¡@2018-12-13 09:58

med.sina.com/article_detail_100_2_57451.html

¦bªüº¸¯ý®üÀq¯f»â°ì¡A¨S¦³¥ô¦ó¤@®a¤½¥q¾D¹Jªº¥¢§Q¯à¤ñ§¨Ó§óºGµh¡C¦ý¬O¡A³o¨Ã¤£ªýê³o­Ó»sÃÄ¥¨¤H¦A¦¸¤Uª`ªüº¸¯ý®üÀq¯f¸ê²£¡A¨Ãñ­q¤@¶µÁ`ÃB20»õ¬ü¤¸ªº¥æ©ö¡C

§¨Ó³o¦¸»PAC Immune¤½¥q¦X§@¶}µoªº®Ö¤ß¸ê²£¬O¤@´Ú¥N¸¹¬°ACI-3024ªºÃĪ«¡A³B©óÁ{§É«e¶¥¬q¡C

AC Immune ¤½¥q12¤ë12¤é¦­¤W©ÜÅS¡A»P§¨Ó¹F¦¨¤F·sªº¦X§@¡AÀò±o8000¸U·ç¤hªk­¦­º¥I´Ú¡A6000¸U·ç¤hªk­¦¤¤´Á¨½µ{ª÷¡A¨ä¥L17»õ¬ü¤¸ªº¬ãµo¡Bµù¥U¤Î¤W¥«¨½µ{ª÷¡C²£«~¤W¥««á¡AAC Immune¥iÀò±o§CÂù¦ì¼Æªº¾P°â¤À¦¨¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/12 ¤U¤È 01:46:47²Ä1062½g¦^À³
¤Úª÷´Ë¯f¤£¬O¦Ñ¤H¯f ¥x¤jÂå°|³Ì¦~»´±wªÌ18·³

www.chinatimes.com/realtimenews/20181212002085-260405

¥x¤jÂå°|¯«¸g³¡¥D¥ô§d·ç¬ü«ü¥X¡A­Y¬O¤Úª÷´Ë¯f©µ»~ªvÀø¡A®£·|¥[³t¥¢¥h¦æ°Ê(¥¢¯à)¡Bªí¹F¯à¤Oªº³t«×¡A¼W¥[¦X¨Ö¥¢´¼»P¼~Æ{¯g(¥¢¤ß)ªº¡u4¥¢¡v­·ÀI¡C

¥D¦]¬O¤Úª÷´Ë¯fªº¸£³¡¥\¯à·l¶Ë¤£¥i°f¡A¦pªG¨S¦³¤Î¦­µo²{¡BªvÀø¡A±N·|¥[§Ö±wªÌ¥X²{°Ê§@»Ùê¡B³à¥¢¦æ°Ê¯à¤Oªº®É¶¡¡A¤]·|³y¦¨±wªÌ¥¢¥h¤f»yªí¹F¯à¤O¡C¾Ú²Î­p¡A¬ù2¦Ü3¦¨±wªÌ¿©¯f±ß´Á·|¥X²{¥¢´¼°ÝÃD¡A§ó¦³43¢H¯f±w·|¦]¯e¯f´c¤Æ¦Ó¨Öµo¼~Æ{¯g¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/3 ¤U¤È 04:28:50²Ä1061½g¦^À³
´ä¥æ©Òªº³W©w

(Ãþ¦ü©ó¥xÆWªº¤jªÑªF©M¸³ºÊ¨Æªº³W½d)

¸T°â³W©w

5.1 ¡m¥DªO³W«h¡n²Ä 10.07(1)±ø¡]¡m³Ð·~ªO³W«h¡n²Ä 13.16A(1)±ø¡^­q©ú¡A°£¤W¥«¤å¥ó¤º´£¤Îªº°âªÑ¥~¡A¦bµo¦æ¤H¥Ó½Ð¤W¥«®É¥Zµoªº¤W¥«¤å¥ó¦C¬°µo¦æ¤H±±ªÑªÑªFªº¤H¤h©Î¤@²Õ¤H¤h¤£±o¡G

(a) ¦Û¤W¥«¤å¥ó¤¤©ÜÅS±±ªÑªÑªF«ù¦³ªÑÅv·í¤é°_¦Ü

¤W¥«¤é´Á°_­pº¡ 6 ­Ó¤ë¤§¤é´Á¤î´Á¶¡¡]¡u­º¤»­Ó¤ë´Á¶¡¡v¡^¥X°âªÑ¥÷¡F¤Î

(b) ¦b­º¤»­Ó¤ë´Á¶¡©¡º¡·í¤é°_­pªº 6 ­Ó¤ë¤º¡]¡u²Ä¤G­Ó¤»­Ó¤ë´Á¶¡¡v¡^¥X°âªÑ¥÷¡A

¥H­P¸Ó¦W¤H¤h©Î¸Ó²Õ¤H¤h¦b¥X°âªÑ¥÷«á¤£¦A¦¨¬°±±ªÑªÑªF ¡C

3 ¡u±±ªÑªÑªF¡vªº©w¸q¤ÎÄÀ¸q

¬ÛÃö¡m¤W¥«³W«h¡n±ø¤å

3.1 ¡m¥DªO³W«h¡n²Ä 1.01 ±ø¡]¡m³Ð·~ªO³W«h¡n²Ä 1.01 ±ø¡^©w¸q¡u±±ªÑªÑªF¡v¬°:

(i) ¥ô¦ó¦³Åv¦bµo¦æ¤HªºªÑªF¤j·|¤W¦æ¨Ï©Î±±¨î¦æ¨Ï 30%¡]©Î¡m¤½¥q¦¬ÁʤΦX¨Ö¦u«h¡n¤£®É³W©w·|IJµo±j¨î©Ê¤½¶}­n¬ù©Ò»Ýªº¨ä¥L¦Ê¤À¤ñ¡^©Î 30% ¥H¤W§ë²¼Åvªº¤H¤h©Î¤@²Õ¤H¤h¡F©Î

(ii) ¦³¯à¤O±±¨î²Õ¦¨µo¦æ¤H¸³¨Æ·|ªº¤j³¡¤À¦¨­ûªº¤H¤h©Î¤@²Õ¤H¤h ¡C

ºK¦Û att.hkex.chinalaw.com/tr_9291_11382.pdf

­Y¦³­×¥¿ªº·sª© ½Ð§ó¥¿

ÁÂÁ¤j®a!

·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/3 ¤U¤È 03:43:52²Ä1060½g¦^À³
Ãö©ó¬ü°êIPO§Ú§ä¨ì©_´º¦b¥²´Iºô¥H«eªº°Q½×

www.berich.com.tw/Rproject/DP/TalkTalk/Talk_Detail.asp?ii=696&CNpg=1

·|­û¡Ggaster8000 µoªí®É¶¡:2005/8/31 ¤U¤È 09:17:58²Ä 26 ½g¦^À³

4. IPO«áªѪF¶·¸g180¤Ñ³¬Âê´Á«á©l¯à½æ¥X

¤W­±³oÂI§Úı±o«Ü­«­n¡A¬O­n¸òÀH®ü¥~¤W¥«ªºªÑªF»Ý­nª`·Nªº

³o¬O¬ü°ê¹L¥hªºª¬ªp¡A²{¦bªk¥O¬O§_¦³§ó§ï§Ú´N¤£ª¾¹D¤F

¤Ï¥¿®É¶¡Á٫ܤ[¡A¤ß®®¤]¤£¤@©w·|¤U¿³ÂdÂà®ü¥~IPO

¥¼¨ÓÂà®ü¥~IPO¤]¤£¤@¥u¦³¤ß®®³o¤@ÀɪѲ¼

§Ú§ä¨ìªº¸ê®Æ´N©ñ¤W¨Ó¤À¨É¡A¦³®É¶¡¥i¥H§â©_´ºªº°Q½×¦ê¬Ý¹L¡A³o¨Ç³£¬OÄÝ©óÃB¥~ªºª¾ÃÑ

¦U®aÀç·~­û¤]¤£¤@©w«Ü±M·~¡A¥i¯à°Ý¤£¨ì

´¿¸g¡A§Ú¸ß°Ý¦U®aÃÒú³°Ó½Æ©e°U®ü¥~³øµ|°hµ|ªí®æ°ÝÃD¡A¤]³£Âà¤F¦n³q¹q¸Ü¤~°Ý¨ì......

·|­û:¤j¤á¤H®a10140174µoªí®É¶¡:2018/12/3 ¤U¤È 12:43:33²Ä1059½g¦^À³
¤µ¤Ñ«ç»ò¶q³o»òªº¤j? Ãø¹Dºô¤Íªº²q´ú¬O¯u? ÁÙ¬O¤T¤H¦¨ªêªü?
·|­û:YOYO10140343µoªí®É¶¡:2018/12/3 ¤W¤È 09:44:46²Ä1058½g¦^À³
¦pªG¬O²q´úªº,§Ú·Q´N¤£­n¦b³o¸Ìµoªí,¥H§K¼vÅT¤ß¤Íªº§ë¸ê§PÂ_,¤½¥qªº§G§½¦³¨ä¹D²z,¤j®aÀ³¸Ó¤@­P»{¦P¥ý§â©ú¦~ªì¨B¸Ñª¼§¹¦¨,¤~¯à©w¦ì¤½¥q»ù­È,¤£µM¦b¥ô¦ó¦a¤è±¾µP,³£没¦³·N¸q.
·|­û:¤p©¯¹B10141538µoªí®É¶¡:2018/12/3 ¤W¤È 09:03:09²Ä1057½g¦^À³
¥xÆW¥Í§ÞÀô¹Ò¨Ã¨S¦³¨º»ò®t..¤Ï¦Ó¬O±NÁÚ¦V°ª¦¨ªø...

¦b®ü¥~IPOªºµ|°È°ÝÃD¯uªº¬O³Â·Ð...¦Ó¥B¯Ó¶O®É¶¡¸û°ê¤ºIPOªø...

¤£½×¦b­þIPO...

¦ý¤j®a·Q¥²³£¬O»{¦P¤ß®®ªº·sÃÄ¥«³õ¼ç¤O¥H¤Î¬ãµo¯à¤O¤~·|ªø´Á§ë¸ê...

´Á¬ß¤½¥q¦h¤À¨É·sÃĶi«×¸ê°T...§l¤Þ§ó¦h¥«³õ§ë¸ê¤H...

¥H¤W~~¨Ñªø´Á§ë¸ê¾Ô¤Í­Ì°Ñ¦Ò

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/3 ¤W¤È 07:54:08²Ä1056½g¦^À³
ÁÂÁ¤p³ì¤jªº¤À¨É

¤j®a±q¤£¦P¨¤«×¥Xµo , «Øºc¤@­Ó¶°«ä¼s¯qªº¥­¥x , ±N¦UºØª¬ªpªº§Q¹ú±o¥¢§e²{ , ¹F¤¬¬Û¥æ¬y ¬Û¤¬¾Ç²ßªº¾÷·|

Åý¤j®a¥i¥H¦p¤p³ì¤jªººc·Q --- ·Q¯d·Q¨«ªºªÑªF³£¥i¥H¦³©ÒÂkÄÝ

©Ò¥H«Ø½Ð¤½¥q­Y¦³©Ò¸¡®× , ½ÐºÉ§Ö¿ì²z¤@À³µ{§Ç , ¤½§i¶gª¾

¨Ãµ¹¤j®a¦³¨¬°÷ªº®É¶¡ , ±q®e¦a¤W¤U¨® , »«¥D³£¯àºÉÅw

ÁÂÁ¤j®a!

·|­û:¤p³ì10135960µoªí®É¶¡:2018/12/3 ¤W¤È 06:09:22²Ä1055½g¦^À³
²q·Q¤jªº¬Ýªk»P§Ú¤@­P,

¨ä¥¦¤H¦CÁ|¦b¥xÆW¤W¥«ªº¬Ýªk,

³£¬O¹ú¤j©ó§Qªº,¥ú´NÄw¸ê¨Ó¬Ý,¦b¥xÆW¹ï¥Í§Þ¦p¦¹¤£¤Íµ½Àô¹Ò,¥u·|¦Û°Q­W¦Y

´`¥H©¹©_´º¼Ò¦¡,©¹®ü¥~IPO,ªÑªFµ¥¤ñ¨Ò´«ªÑ,·Q¯d·Q¨«ªºªÑªF³£¥i¥H¦³©ÒÂkÄÝ

¦p²q·Q¤j©Ò¨¥,Äw¸ê»PIPO³sµ²,ºÉ§Ö§ä¨ì¿ú±N¨ä¥¦pipelines ¶}©lÁ{§É,¤~¬O²Å¦XªÑªF³Ì¤j§Q¯q

½²¸³¦bªÑªF·|»¡ªº¤GÂIÃö©ó¸ê¥»¥«³õªº¬Ýªk«Ü­«­n,¦³¥hªº¤H¤£¥é¦^·Q¤@¤U

¥i¥H±q¥H¤W¤GÂI«ä¯Á¸³¨Æªøªº¬Ýªk

Á`¤§,¨«¥X¥h,¤~¬Ý±o¨£¥@¬É¤§¤j

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/2 ¤U¤È 10:08:08²Ä1054½g¦^À³
ÁÂÁ¤j®aªº¤À¨É

°²¦p¯à¦b¥xÆW¤W¥«Âd·íµM³Ì¦n¡A¥i¥H¬Ù¥h®ü¥~©Ò±oªº³Â·Ð

¦ý¬O±N¬ãµo¡B°]°È¥D¤O½Õ©¹­»´ä¤ß®®¡A¦Ó¤£¬O¬°¤F¨ì­»´ä¤W¥«¡A³o´N¶W¥G­Ó¤HÅÞ¿è©Ò¯à§PÂ_¤F

ÁÂÁ¤j®a¡I

·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/2 ¤U¤È 09:40:17²Ä1053½g¦^À³
¹³¥xÆW¤j¦P¤½¥q·m¸gÀçÅv·s»D«Ü±`¤W³ø

ªÑªF«ùªÑ°÷¦h¤]«Ü¤Ö¤£¤¶¤J¸gÀçÅvªº

¦³¤@ÀɧڦbÆ[¹îªº¥¼¤W¥«¤½¥q´I¥Ð¹q¾÷¸³¨Æªø´N¦b©ê«èªÑªF¤¤¿û¤¶¤J¸gÀç

www.chinatimes.com/newspapers/20150819000039-260202

¤¤¿û·í¤W´I¥Ð¹q¾÷ªÑªF«á´NÅý¸³¨Æªø«Ü«á®¬

¸³¨Æªø¦b³o½g·s»D©ê«è»¡

¤¤¿ûºX¤Uªº¤¤¬Õ§ë¸ê¡A¥h¦~§¹¦¨¤JªÑ´I¥Ðªº²Ä2¤Ñ´N¶}¥X±ø¥ó¡A¡u¸³¨Æªø¤£·|´«¤H¡A¦ý°]°Èªø»P·|­p®v¨Æ°È©Ò³£­nºM´«¡v¡C±iª÷¾WÁöµM²n§ÖµªÀ³¡A¦ýÅý¥L®ðµ²ªº¬O¡A¡u¤¤¿û¬£¾nªº°]°È¥DºÞ¸gÅ礣¨¬¡A¥uÀ´¦¨¥»·|­p¡A«o¨­­Ý°]°È³¡»PºÞ²z³¡°ÆÁ`¡A´I¥Ð­û¤u«Ü¤£ªA³o¦ì¥DºÞªº¾Ç¸g¾ú¡v¡B¡u³o¦ì°]°È¥DºÞ¤£À´Â¾³õ­Û²z¡A»â´I¥ÐªºÁ~¤ô¡A«o¨Æ¨Æ³£¦V¤¤¿û³ø§i¡v¡C

·|­û:YOYO10140343µoªí®É¶¡:2018/12/2 ¤U¤È 09:32:15²Ä1052½g¦^À³
¥H­Ó¤H¦b¸ê¥»¥«³õ¸gÅç¨Ó¬Ý,ªY½à¼Æ¦r¬üªºµû½×¸û²Å¦X¥«³õÅÞ¿è,¥B¤w¥Ñ¥xÆW¥«³õ¤U¥«ªºªÑ²¼»¡­n¥h­»´äªº,¨ì²{¦b¼v¤l³£没¦³,¥«³õ²{¦b¤]没¤H°Q½×,ÁÙ¦³¤@®a³ßX±µ¨ì¬ü°ê©x¥q¥i¯à¤]»»»»µL´Á,²{¦b¥xÆW¥«³õ¤]没¦³¨ì®ü¥~±¾µPªº¼ö«×¤F,¤F¤£°_µo­ÓGDR©ÎADR¤]ºâ®ü¥~±¾µP,¤ß®®À³¸Ó¬O¥¼¨Ó­n¨«GDR©ÎADR³o±ø¸ô§â,¤ß®®¥Ø«e±ø¥ó°ò¥»¤W¬O¤£²Å¦X¨ì­»´ä±¾µPªº¼Ð·Ç,¦Ó¥B没¤H·|ªá¤j§â¶r²¼¨ì®ü¥~±¾»t,¤S»´©ö§â¸gÀçÅvÅý¥X,¦b¥xÆW±¾µP,À³¸ÓÁÙ¬O¤½¥q¥Ø¼Ð
·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/2 ¤U¤È 08:47:51²Ä1051½g¦^À³
­»´ä±¾µPªÑªF±N·|·|¬O¤¤¸ê©Î´ä¸ê©~¦h¡A¤£·|¹³¥x¿n¹qªº¥~¸ê¨º»ò³æ¯Â

½²¸³¨Æªøªº20%ªÑ¥÷¤]·|¦A³Qµ}ÄÀ

·d¤£¦n·|¹³¥_·¥¬P¤@¼Ë

¶}¤@­ÓªÑªF·|¸gÀçÅv´N³Q®³¨«

¸³¨Æªø­n´«¤H°µÅo......

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/2 ¤U¤È 07:37:31²Ä1050½g¦^À³
ªY½à¼Æ¦r¬ü¤j¬O­Ó°ª¤â

·PÁ±zªº«ü±Ð»P«ü¾É

±z©Ò¦CÁ|ªº´ä¥æ©Ò¤å¥óªñ200­¶ ¡A¤p§Ì®£®ø¤Æ¤£¨}¡A±¾¤@º|¸UÀ³¬°±`ºA

¥xÆW¤ß®®­n©¹­þ¨à±¾µP ¡A¤½¥q©|¥¼¤½§i ¡A¤p§Ì¬O«ù¶}©ñªººA«×

¤p§Ì«e½g¨Ì11/28¤½¥q­«¤j·s»Dªº²q´ú ¡A¤]¶È¬O­Ó¤Hªº¤@ºØ²q´ú ¡AµLÃö¥G¤½¥qªº¨Mµ¦

¸Ó­«¤j·s»D¤½¥q±N¬ãµo°ÆÁ`¤Î°]°È¸g²z½Õ©¹­»´ä¤ß®® ¡A·íµM¬O¤p§Ì²q´ú«e¶i­»´äªº¥D­n¨Ì¾Ú

·í®É ¡A¤p§Ì¬O·Q

­Y¤½¥q±N¥xÆW¤ß®®§@¬°Àç¹B¥DÅé ¡A«h¯d¦b¥xÆW ©Î«e©¹¬ü°ê ­»´ä ¡A³£¥i«O«ùµÛ¼u©Ê ; ±N¥D­n¤H­û½Õ¥ô­»´ä¤ß®® ¡A¦ü¥G¤£¦X¦¹ÅÞ¿è ? ¦¹¨ä¤@¤]

¤S±z©Ò´£ªº [ Àç¹B¸êª÷ ] ¤Î [ ±M·~§ë¸ê¤H ] ªº°ÝÃD

¹ï©ó­n«e©¹­»´äªº¤½¥q À³¤£¬O¤@ºØ¤£©ö¸Ñ¨Mªº°ÝÃD ¡A¸Õ·Q³s¤W¥««eªº±M·~§ë¸ê¤Hªº§ë¸ê³£·d¤£©w ¡A¤S«ç¯à¤W¥«¥h¶Ò±o¸êª÷©O ?

³o¨â¶µ¡A´ä¥æ©Ò°µ³o¼Ëªº³W½d :

<<<

¾A¥Î©ó¥Íª«¬ì§Þ¤½¥qªº¤W¥«±ø¥ó

18A.02 ®Ú¾Ú¥»³¹¥Ó½Ð¤W¥«ªº¥Ó½Ð¤H¡A°£¥»³¹ªº³W©w¥~¡A¥ç¶·²Å¦X¡m¤W¥«³W«h¡n²Ä¤K³¹¡]²Ä 8.05 ±ø°£¥~¡^ªº³W©w¡C

18A.03 ®Ú¾Ú¥»³¹¥Ó½Ð¤W¥«ªº¥Ó½Ð¤H¥²¶·¡G¡X

(1) ¦V¥»¥æ©ö©ÒÃÒ©ú¨Ã¥O¨ä½T«H¥Ó½Ð¤H¦X¸ê®æ¤Î¾A¦X¥H¥Íª«¬ì§Þ¤½¥qªº¨­¥÷¤W ¥«¡F

(2) ¤W¥«®Éªº¥«­È¦Ü¤Ö¹F 15 »õ´ä¤¸¡F

(3) ¦b¤W¥««e¤w¥Ñ¤j­P¬Û¦PªººÞ²z¼h¸gÀç²{¦³ªº·~°È¦Ü¤Ö¨â­Ó·|­p¦~«×¡F¤Î

(4) ½T«O¥Ó½Ð¤H¦³¥R¨¬ªºÀç¹B¸êª÷¡]¥]¬A­p¤J·s¥Ó½Ð¤H­º¦¸¤W¥«ªº©Ò±o´Ú¶µ¡^¡A¨¬¥iÀ³¥I¶°¹Î¥Ñ¤W¥«¤å¥ó¥Zµo¤é´Á°_­p¦Ü¤Ö¤Q¤G­Ó¤ë©Ò»Ý¶}¤äªº¦Ü¤Ö 125%¡C

¸Óµ¥¶}¤äÀ³¥D­n¥]¬A¡G (a) ¤@¯ë¡B¦æ¬F¤ÎÀç¹B¶}¤ä¡]¥]¬A¥ô¦ó¥Í²£¦¨¥»¡^¡F¤Î (b) ¬ãµo¶}¤ä¡C

µù 1¡G ¥»¥æ©ö©Ò¹w´Áµo¦æ¤H·|±N­º¦¸¤W¥«©Ò±o´Ú¶µ¤j³¡¤À¥Î©ó¤ä¥I¤W­z¶}¤ä¡C

µù 2¡G «ö¥»±ø­pºâ©Ò»ÝÀç¹B¸êª÷®É¥i¤ð¶·­p¤J¸ê¥»¶}¤ä¡A¦ý­Y¸ê¥»¶}¤ä¬O¨Ó¦Û ­É´Ú¡A¬ÛÃöªº§Q®§¤ÎÁÙ´Ú±¡ªp«h¶·­pºâ¦b¤º¡C

¤Î

85. ¾¨ºÞÁp¥æ©Ò°ò©ó¤W­z­ì¦]¦Ó¤£ÀÀ¹ï¦p¦ó¬É©w¡u¸ê²`§ë¸êªÌ¡v¤Î¡u¬Û·í¼ÆÃBªº§ë¸ê¡v¶i¦æ ©ú½u´ú¸Õ¡A¦ý§Ú­Ì¥ç»{¦P¦n¨Ç¦^À³¤H¤hªº·N¨£¡A´N¬O¦V¥«³õ´£¨Ñ¶i¤@¨B«ü¤Þ¤Î°ò·Ç¦³§U ¥«³õ¦³§ó²M´·ªº»{ÃÑ¡C¬°¦¹¡A

Áp¥æ©Ò¤@¯ë·|¡G

(a) ±N¡]¤U¦CÃþ§Oªº§ë¸êªÌµø¬°¸ê²`§ë¸êªÌªº¨Ò¤l¡]¶È§@»¡©ú¤§¥Î¡^¡G

(i)±MªùªºÂåÀø«O°·©Î¥Íª«¬ì§Þ°òª÷¡A©ÎºX¤U¦³±Mªù©Î°¼­«©ó§ë¸ê¥Íª«»sÃÄ»â°ìªº¤À¤ä¡þ³¡ªùªº¤j«¬°òª÷¡F

(ii)¤j«¬ªº»sÃÄ¡þÂåÀø«O°·¤½¥q¡F

(iii)¤j«¬ªº»sÃĤ½¥q¡þÂåÀø«O°·¤½¥qªº­·ÀI§ë¸ê°òª÷¡F¤Î

(iv) ºÞ²z¸ê²£Á`­È¤£¤Ö©ó 10 »õ´ä¤¸ªº§ë¸êªÌ¡B§ë¸ê°òª÷©Îª÷¿Ä¾÷ºc¡F¤Î

(b) µø¤U¦C§ë¸êª÷ÃB¬°¡u¬Û·í¼ÆÃBªº§ë¸ê¡v¡A¥i§@«ü¼Ð°Ñ¦Ò¡G

(i) ´N¥«­È¤¶¥G 15 »õ´ä¤¸¦Ü 30 »õ´ä¤¸ªº¥Ó½Ð¤H¦Ó¨¥¡A§ë¸êª÷ÃB¤£¤Ö©ó¥Ó½Ð¤H ¤W¥«®É¤wµo¦æªÑ¥»ªº 5%¡F

(ii) ´N¥«­È¤¶¥G 30 »õ´ä¤¸¦Ü 80 »õ´ä¤¸ªº¥Ó½Ð¤H¦Ó¨¥¡A§ë¸êª÷ÃB¤£¤Ö©ó¥Ó½Ð¤H ¤W¥«®É¤wµo¦æªÑ¥»ªº 3%¡F¤Î

(iii) ´N¥«­È¶W¹L 80 »õ´ä¤¸ªº¥Ó½Ð¤H¦Ó¨¥¡A§ë¸êª÷ÃB¤£¤Ö©ó¥Ó½Ð¤H¤W¥«®É¤wµo¦æªÑ¥»ªº 1%¡C

½Ðª`·N¡A¥»¬q©Ò­z¶È¬°§PÂ_¥Íª«¬ì§Þ¤½¥q¬O§_¾A¦X¤W¥«®É¦p¦óÂç©w¡u¸ê²`§ë¸êªÌ¡v¤Î¡u¬Û ·í¼ÆÃBªº§ë¸ê¡v¦Ó´£¨Ñªº«ü¤Þ¡C

>>>

¦AªÌ

¥R¨¬ªºÀç¹B¸êª÷¥]¬A­p¤J·s¥Ó½Ð¤H­º¦¸¤W¥«ªº©Ò±o´Ú¶µ¡A©Ò¥HÀ³µLª§Ä³

¤TªÌ

­»´ä¤ß®®Á`¥«­ÈÀ³¤£·|¥u¹F³Ì§C¼Ð·Çªº15»õ´ä¤¸ ¡A­n¥Î30»õ´ä¤¸ªº¼Ð·ÇÀ³¤]¤£¬OÃø¨Æ ?

¤S°·¥ÃÅv§Qª÷ ©M¤ß¬ùªº°ÝÃD

§Ú·Q

¨C®a¤½¥qªº²£«~ ¥«³õ°âÃB ±ÂÅv¹ï¶H³£¤£¤@¼Ë ¡AÅv§Qª÷²v©Î¦³¤£¦Pª¬ªp

±ÂÅv¹ï¶H¶V¤j©@ , Åv§Qª÷²v¥i¯à¶V§C , ´N§Ú¬Ý¹Lªº¸ê®Æ , ¬ù¦b18% ~ 32%(¤T´ÁÁ{§É¦Û¤v§¹¦¨ªº»ù½X , ¤£§t¤¤¸Î»PTHªº¦X¬ù)

¥«³õ°âÃB¨«°ª , Åv§Qª÷²v¤]·|¸òµÛ½Õ°ª , ¦³ªºÁÙ¦³¨½µ{ª÷

·íµM , ¨C­Ó­Ó®×³£¦³¦Û¤v¿W¥ßªº¯SÂI , Åv§Qª÷²v ¨½µ{ª÷¤£¯à¤@·§¦Ó½×

·íªì¤ß¬ùªº³]¥ß , ¤p§Ì¤]´¿´Nµ|­tªºÆ[ÂI ²q´ú¦b¥x¤W¥«ªº¾÷·|¿@¤F

¦ý²{¦b¬Ý¨ì¤½¥q11/28ªº¤½§i , Åý§Ú¦b¥x¤W¥«ªº¬Ýªk²¤¦³°Ê·n

¤]³\¤ß¬ùªº³]¥ß , ¤]¥i¥u¦b©Ó±µ¥Ø«eÁÙ¦b«H°UªºªÑ²¼¦Ó¤w

¥t¥~®ü¥~©Ò±oªº°ÝÃD

ªº½T , ¦b¥xÆW¤W¥« , ´N©~¦í¦b¥xÆW±o§Ú­Ì , ¥i¥H¬Ù«o¤@¨Ç³Â·Ð

³Ì¥D­nÁÙ¬O®ü¥~©Ò±o½Òµ|ªº°ÝÃD --- ¸Ó¦~«×®ü¥~Àò§Q¶W¹L¥x¹ô670¸U , ­n¦©³Ì§Cµ|­t20%

¨ì­þÃäIPO , ¬O¤½¥q¿Å¶q½Ñ¦h¦]¯Àªº¨Mµ¦ , ÁÙ¦³¦h¼ÆªÑªFªº¨Mij , «D¨C­Ó­Ó¤H©Ò¯à¼vÅT

µM¦n¼ÐªºÃø´M§r! ­Y¯uªº¨ì®ü¥~ IPO , Ãø¹D§Ú­Ì´N­n¦]¬°¥²¶·Ãº¯Ç20% ªºµ|­t¦Ó§âªÑ²¼½æ¤@½æ , ¤£ÁȤF¶Ü ? ¬Û«H±z§Ú³£¤£·|

´N¬O¦]¬°¥xÆW¥«³õ¹ï·sÃĪѯʥF»{ÃÑ , ¾É­P¤£¤Ö¦³¼ç¤Oªº¤½¥q³QÄY­«§C¦ô

­n¬O§Ú­Ì¬O³o¨Ç¤½¥qªº¸gÀçªÌ , ®£©È¤]·|·Q­n¥X¨« , Åý¥@¬É¬Ý±o¨£?!

¦Ü©ó¤j¤áªº°ÝÃD

­Y¥L­Ì¦³°ÝÃD , ´N¤Ó¤p¬Ý¥L­Ì¤F

´CÅ餣¬O¦³³ø¾É°²¥~¸êªº¦s¦b¶Ü? ³o¤£¬Oµ|­tªº¦Ò¶q¶Ü ?

°²³]¤ß®®¥¼¨Ó¥i¥H¦¨¥\ , ¨º¤j¤á·|«ç»ò°µ , ·íµM¬OÃþ¦ü¥xªÑ¥H«e¦³ÃÒ©Òµ|®Éªº°µªk , ¯E¹©ª©¥H«e°Q½×¬Æ¦h , ¦b¦¹¤£¦A¦h¼L

Á`¤§

¦b¤½¥q©|¥¼¤½§G¤§«e , ¥ô¦ó¤è®×³£¥i³Q²q´ú , ³£¦³¥i¯à

µM¥h¦~¦Ü¤µ , ¿ð¿ð¥¼¨£¤½¥q¼W¸ê , ¤½¥q©Î¦³¤@®M»PIPO¤@°_¦Ò¶qªº­pµe§a!?

¥H½²±Ð±Â¹ïÁ{§É¥Î¤ß¤§²` ³W¹º¤§¦n

©ñ½Ñ°]°È­pµeÀ³¸Ó¤]¥i¦p¬OÆ[ , ¤£¬O¶Ü!?

ÁÙ¬O¦Ñ¸Ü¤@¥y , ²q´ú´N¬O²q´ú , µLÃö¥G¨Æ¹ê , Åý§Ú­ÌÀR­Ô¤½¥q¤½§i

ªÑ»ù¥Ñ¥«³õ¨M©w , ºÝ¬Ý¤j¤á«ç»ò¬Ý «ç»ò°µ !

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/2 ¤U¤È 03:45:59²Ä1049½g¦^À³
¶R½æ¥xªÑ¦³ÃÒ¨é¥æ©öµ|¤d¤À¤§3 ¤Î¨é°Óªº¤âÄò¶O

ªÑ»ùÀò§Q¦³®tÃB¤£¥²Ãºµ|

¦ÓªÑ§Q·|¯Ç¤J©Ò±o¤¤¥t¥~¤]¦³°·«O¸É¥R«O¶O

www.businesstoday.com.tw/article-content-80405-164094

®ü¥~¦¬¤J¶·­núµ|¡A­»´ä¤W¥«³o­Ó»Ý­n¤F¸Ñ

www.moneydj.com/tax/content.djhtm?a=04-06

¦pªG¤ß®®­»´ä¤W¥«¡A§ë¸êª÷ÃB¶W¹L¤d¸U¤¸¥H¤W¡A¶R½æªÑ²¼ªºÀò§Q¡A¶W¹L670¸U§Kµ|ÃBªº¤j¤á

·|¤ñ¥xªÑ¶R½æúµ|ú§ó¦h¡A©Ò¥H¹ï¤j¤á¨Ó»¡¤ß®®¯d¦b¥xÆW·|§ó¦³§Q

¥xÆW¤H¶R½æ¥xªÑ¡AÀò§Q¤£¥Î¯Ç¤Jºî©Òµ|

®ü¥~¦¬¤J¬O¶·­n¥Ó³øúµ|ªº³á

¦b­»´ä¤W¥«¡A¥Ó³ø®ü¥~Àò§Qªº®É­Ô¶·¦Û¦æÁ|ÃÒ¥æ©ö¦¨¥»

¥Ó³ø©Ò±oµ|¡A§ó½ÆÂø­n¦h§ó¦hªº¸ê®Æ

¨S¯d¦í²{¦b¿³Âd¥æ©ö¸ê®Æ¡Aµ¥¤U¿³Âd¡A®ü¥~IPO®É´Nª¾¹D³Â·Ð¤F

·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/2 ¤U¤È 02:27:18²Ä1048½g¦^À³
¤¤°ê¥«³õ¬O¥ÑÂå®v±À¾P½æÃÄ¡A§Q¼í«Ü¤j¤@³¡¤À³Q±À¼s¶O¦Y±¼

www.trpma.org.tw/index.php/tw/news/item/3726

°·¥Ã¦b¬ü°ê¥«³õ¦³¾÷·|¨ú±o¤T¨ì¥|¦¨ªº¾P°âÅv§Qª÷¤ñ­«¡A¤j³°¤è­±«h¬°8¨ì12%

³o«h·s»D°·¥Ã¯à®³¨ìªº´N³Q¦ô±o«Ü§C

³o´N¬O§Ú²q¥i¯à­n¦Û¤v½æªº­ì¦]

¤ß®®ºë¯«¤Àµõ¯gSND¨t¦C¬O¦b¬ü°ê¡B¥[®³¤j¥H¤Î¼Ú¬w³Ì¦h40­Ó¤¤¤ß¦¬®×¡A¤¤°ê¥«³õ¦³¥i¯àÁÙ­n°µ¾ô±µ¸ÕÅ礧Ãþªº

¸Ñª¼«á¤¤°ê¤W¥«ÁÙ­n¦n¤@¬q®É¶¡

¤¤°ê¤è­±¤£ºÞÁ{§É©Î¾P°â¶·­n«H¥ôªº°]·|¥DºÞ¨nµÛ¡A­n¤£µM«Ü®e©ö³Q°µ¤â¸}¡C

­ì¥»Á{§É¸ÕÅ窺°e¥ó¡B»s¾¯»s³y¤Î¤j³°¥«³õ©Ý®i¡A¬O¥Ñ¤jªÑªF°·¨È³Wµe

°·¨È¤@ª½¥H¨Ó«÷©R½æªÑ²¼¡A©M¤ß®®¤j·§Ãö«Y¤]¤£·|«Ü¦n¤F

­»´ä³]¥ß¤½¥qªº¥Øªº¤£·|¥u¦³¬O­»´ä¤W¥«

¤U¤@¶¥¬q¬ãµo¥¢´¼¯g­n¦V¤¤°êCFDA¥Ó½ÐÁ{§É¤G´ÁIND

¶·­n©M¤¤°ê§óÀWÁcªº¥æ¬y

¥H«á¤j³°¥«³õªº©Ý®i´N·|¥ÑSyneuRx Neuroscience HK Ltd.¨Ó©Ó¾á

¤£·|¦A¸g¹L°·¨È¤F

datagovtw.com/company.php?id=50858859

©ÒÀç¨Æ·~¸ê®Æ ¡P ¤ß¬ù¦³­­¤½¥q

H201010: ¤@¯ë§ë¸ê·~

¥Nªí¤H©m¦W VIVIAN YALING WU

ÁÙ¦³¦pªG¤ß®®­n­»´ä¤W¥«¡A³]¥ß¤ß¬ù¦³­­¤½¥q®Ú¥»¦h¦¹¤@Á|

¤½¥q¸³¨Æ¸gÀç°ª¼h³]¥ß§ë¸ê¤½¥q¥Øªº¬O­nÂಾ«ùªÑ¸`µ|

·|­û:ªY½à¼Æ¦r¬ü10147157µoªí®É¶¡:2018/12/2 ¤U¤È 12:59:07²Ä1047½g¦^À³
²q·Q¤j§Úı±o§A°Q½×Á`¥u°Q½×¤@¥b¡AÁÙÁô´c´­µ½

­»´ä¤@¼Ë¬O¤¤¤å¤S¤£¬O¶·¦³¥~»y¯à¤Oªº­^¤å¡A¸ê®Æ«Ü®e©ö§ä¡A¸ê®Æ¤ñ§A¶Kªº¥xÆW·s»D§ó¸Ô²Ó

§A¤£¶K­»´ä©x¤è¤@¤â¸ê®Æ¡A³o­Ó¶K¥xÆW¤G¤â·s»D

www.hkex.com.hk/News/Market-Consultations/2016-to-Present/February-2018-Emerging-and-Innovative-Sectors?sc_lang=zh-HK

www.hkex.com.hk/-/media/HKEX-Market/News/Market-Consultations/2016-Present/February-2018-Emerging-and-Innovative-Sectors/Consultation-Paper/cp201802_c.pdf

²Ä¤G³¹82±ø³W©wÀç¹B¸êª÷¶·²[»\¥¼¨ÓÀç¹B¶}¤ä¦Ü¤Ö125%

¥t¥~¥xÆW·s»D

money.udn.com/money/story/10161/3304235

¥²¶·¦Ü¤Ö¤@­Ó¸g°ê»Ú¥D­n°ê®a»{¥iªºÁ{§É¤G´Á²£«~¡A¦AªÌ¥²¶·¦³¤j³°©Î­»´ä±M·~§ë¸ê¤H°Ñ»P¨Ã¦¨¬°¤jªÑªF¡A¥t¥~¡A¥«­È¼Ð·Ç¥²»Ý¹F´ä¹ô15»õ©Î2»õ¬ü¤¸

³o¤]´N¬O¤U¦C

www.hkex.com.hk/-/media/HKEX-Market/News/Market-Consultations/2016-Present/February-2018-Emerging-and-Innovative-Sectors/Conclusions-(April-2018)/cp201802cc_c.pdf

85.(a)(iv)

ºÞ²z¸ê²£Á`»ù­È¤£¤Ö©ó10»õ´ä¤¸ªº§ë¸êªÌ¡B§ë¸ê°òª÷©Îª÷¿Ä¾÷ºc

¥B¤W¶µ§ë¸ê¤½¥q¶·§ë¸ê¤W¥«®É¤wµo¦æªÑ¥»ªº5%

¤ß®®ªÑªF¨S¦³´ä¸ê©Î¤¤¸ê§a

¥t¥~

²Ä¤G³¹82±ø³W©wÀç¹B¸êª÷¶·²[»\¥¼¨ÓÀç¹B¶}¤ä¦Ü¤Ö125%

²{¦b¤ß®®¸êª÷°÷¶Ü?¥i¥H¼µ¨ì¦Ü¤Ö¨â¦~ªºÀç¹B¨ì­»´ä¤W¥«ªºÀç¹B¤@¦~«á¶Ü?

­»´ä¤W¥«¤£ª¾­n¼f®Ö¦h¤[

¥xÆW§ë¸ê¤H¤S¦h¤Ö¤H¦³­@¤ß¯àµ¥¤@¦~

¦Ó¤@¦~¤ß®®«á¤]®t¤£¦h¸Ñª¼¤F¡A¨º¤ß®®¸Ñª¼¬°¤°»ò¤£ª½±µ¦b¥xÆW¤W¥«Âd´N¦n¡AÁÙ­n¶°é¨ì­»´ä±¾µP

¥xÆW¤W¥«Âd¤]¥i¥H¨ì¬ü°êADR

¥H¤ß®®ªº²£«~©Ê½è¬ü°êADR©ÎIPO§ó±µªñ¥«³õ

½²³Õ¤hªø«Ý¬ü°êADR¹ï¬ü°ê§ë¸ê¤H¨S®É®t°ÝÃD¡A·¾³q§ó¦n

¹ï©ó¤½¥q­«­n·F³¡Âà¥ôSyneuRx Neuroscience HK Ltd.

§Ú¬O²q´ú¤U¤@¶¥¬q¤½¥q­n¶}©l¬ãµo¥¢´¼¯g

SND5­ì®Æ¨ÑÀ³¤Î¥Í²£¤§±MÄݩʬO©M´ò¥_¤­®p¨ª¸Ûñ­q

±µ¤U¨Ó¶i«×´N¬O­n¦V¤¤°êCFDA¤Î¬ü°êUS FDA¥Ó½ÐÁ{§É¤G´ÁIND

Ãĵؤ]¦³¦b­»´ä³]¥ß¤À¤½¥q

¤£±Æ°£¤ß®®·|¹³Ãĵؤ@¼Ë¡A­»´ä³]¥ß¤½¥qªº¥Øªº¬O¥´ºâ¤¤°ê¥«³õ¦Û¤v½æ

·|­û:²q·Q10136148µoªí®É¶¡:2018/12/2 ¤W¤È 07:39:21²Ä1046½g¦^À³
¥xÆW¸gÀÙ·s³ø

¦b [ ­»´ä¥«³õ²¤¶ ] ¤å¤¤

www.tej.com.tw/twsite/TEJWeb/tw/database/doc/hk.pdf

´£¤Î

¥i±µ¨üªº¥qªk¦a°Ï , ¥]¬A

1. ®Ú¾Ú¡m¤W¥«³W«h¡n¡A©ó­»´ä¡B¤¤µØ¤H¥Á¦@©M°ê¡B¶}°Ò¸s®q¤Î¦Ê¼}¹F¦¹¥|­Ó¥qªkÅv°Ï¡]¡u»{¥i¥qªkÅv°Ï¡v¡^µù¥U¦¨立ªº¤½¥q²Å¦X´£¥X¤W¥«¥Ó½Ðªº¸ê®æ­n¨D¡C

2. °£»{¥i¥qªkÅv°Ï¥~¡A聯¥æ©Ò±µ¯Ç 21 ­Ó¥qªkÅv°Ï¬°¤½¥qµù¥U¦¨立¦a¡]Àò±µ¯Ç¥qªkÅv°Ï¡^¡C

¡iµù 1¡j²{®É¡A¦b聯¥æ©Ò¤W¥«ªº¦w¤j略省¤½¥q¥u¦³¤@®a¡A¬°©ó 1999 年¥Ó½Ð¤W¥«ªº§»利金¿Ä¡]ªÑ¥÷¥N¸¹¡G0945¡^¡A¸Ó¤½¥q¬O¦b 2007 年聯¦X¬Fµ¦Án©ú¤½¥¬«e¤W¥«¡C

¡iµù 2¡j¨ä¾l 20 ­Ó¥qªkÅv°Ï¤À§O¬°¡G¿D¬w¡B¤Ú¦è¡B­^Äݺûº¸¨Ê¸s®q¡B¥[®³¤jªüº¸§B¹F省¡B¥[®³¤j不列ÄA­ô倫¤ñ¨È省¡B塞®ú路´µ¡Bªk°ê¡B¼w°ê¡B®æ®¦¦è¡B°¨®¦®q¡B·N¤j利¡B¤é¥»¡B¿A¦è®q¡BÁú°ê¡B¯Ç»Ô¡B盧´Ë³ù¡B·s¥[©Y¡B­^®æ蘭¤Î«Âº¸´µ¡B¬ü°ê¥[¦{¡B¬ü°ê¯S拉µØ¦{¡C

©Ò¥H , ¤½¥q¥²¶·¦b¤W­z¥qªkÅv°Ïµù¥U , ¤è¯à¦b­»´ä¤W¥«

¦]¦¹²q´ú SyneuRx Neuroscience HK Ltd. ©Î¬°¦b­»´ä¤W¥«ªº¥DÅ餽¥q

­Y¦¹ , ±N¨Ó¥xÆW¤ß®®ªºªÑªF±N¥H´«ªÑªº¤è¦¡ , Âର«ù¦³ SyneuRx Neuroscience HK Ltd. ¦b´ä¥æ©Ò¥æ©ö

±z¥u­n¨ì¦³½Æ©e°Uªº¥xÆWÃҨ餽¥q , ¶}¥ß½Æ©e°U±b¤á«K¥i¥æ©ö , ¬ÛÃöªºµ|¨î , ½Ð°Ñ¤§«eªº°Q½×©Î¦Û¦ægoogle

¤S¨Ì¸gÀÙ¤é³ø2018/4/25ªº³ø¾É

´ä¶}©ñ¥¼¬Õ§Q¥Í§Þ·~IPO

2018-04-25 01:33¸gÀÙ¤é³ø °OªÌ½²±Ó«º¡þºî¦X³ø¾É

money.udn.com/money/story/5604/3105607

. ¦b³Ì·sµo¥¬ªº«t¸ßÁ`µ²¤¤¡A¹ï©óµL¦¬¤J¥Íª«¬ì§Þ¤½¥q¡A´ä¥æ©Ò·s¼W³W©w¡AÀÀ¤W¥«¤½¥q¹w´Á¥«­È¤£¤Ö©ó15»õ´ä¤¸¡A¥B­n²Å¦X¦h¶µ­n¨D¡C¥]¬A±q¨Æ®Ö¤ß²£«~¬ãµo¦Ü¤Ö12­Ó¤ë¡B¦Ü¤Ö¦³¤@¶µ®Ö¤ß²£«~¤w¸g³q¹L·§©À¶¥¬q¶i¤J²Ä¤G´Á©Î²Ä¤T´ÁÁ{§É¸ÕÅçµ¥¡C

´ä¥æ©Ò³W©wµLÀ禬¥Í§ÞªÑªº³Ì§CÁ`¥«­È¬° 15»õ´ä¤¸

¥H´ä¹ô/¥x¹ô = 4 ­pºâ , ´«ºâ¥xÆW¤ß®®ªºªÑ»ù ¦Ü¤Ö¦b60¤¸

³o¬O¥H´«ªÑ¤ñ¨Ò ( ¥xÆW¤ß®®/­»´ä¤ß®® ) = 1 ¦ôºâªº ( ·íªì©_´º¨ì¬ü°ê±¾µP±Ä¤@ªÑ´«¤@ªÑ )

°²¦p¤½¥q¯àÅé«ò¦b¿³Âd®É´Á¶R¶iªºªÑªF¤j¦h®M¨c©M©Ó¨üªº·Î¼õ¥B¿³Âdªº±¾µP°Ñ¦Ò»ù¹F168 ¤¸

­Y¤½¥q¯à¥H¹ï¥xÆW¤ß®®ªÑªF§ó¦³§Qªº´«ªÑ¤ñ¨Ò ( ¤ñ¦p1.2 , 1.5 , ¬Æ©Î2 , 3 ; ·N§Y±N­»´ä¤ß®®ªºªÑ¥»©ñ¤j , IPO»ù®æ¥i¥H¤£¥Î±¾¤Ó°ª ) , ·í§@¬O¹ï¥xÆW¤ß®®ªÑªFªº¤@ºØ¸ÉÀv , «h§ó¤£¦b¸Ü¤U

·íµM , ³o©Î·|²o¯A»P­»´ä¤W¥«©Ó¿ì¨é°Óªº·¾³q¨ó½ÕIPO»ù®æ , ¦ý¼f«×Á{§Éªº¶i«×¶i®i , ¥¼¹Á¨S¦³¥i¯à

¥xÆW¤£¤Ö¦³¼ç¤Oªº·sÃĪѳQµuµøªº­ì©lªÑªF·í´£´Ú¾÷ , ªÑ»ù³QÄY­«§C¦ô

¦³¹ê¤O©M§Ó®ðªº¤½¥q°ª¼h·í¿³°_¥X¨«©ÀÀY , ¥Ñ±ý¦R´e®ð¶i¦Ó´­¬Ü¦R®ð

¤p§Ì´Ü¨Ø¤j®aªº²H©w

²H©wªº¤ß , ©Î¨Ó¦Û©ó¹ï½²±Ð±Âªº«H¥ô©M«H¤ß

¦P®É , «D±`·PÁ¤½¥q¹ï©ó±N¨Ó¤W¥«ªº°Ê¦V¥ýµ¹§Ú­ÌªÑªF´£¥Ü , Åý§Ú­Ì¹ï¤½¥q¦h±¡ªº¤ß¨S¦³¿W¦V±I¹æ

³o­Ó¨Mµ¦À³¬O¤½¥q¦Ò¶q¦h¤è¦]¯À , ¥H¤½¥qµo®i©MªÑªFÅv¯q¬°¨ÌÂkªº³Ì§´¾A¤è®×

§Ú·Q , ¦b³o­Ó®ÉÂI°Ê§@ , ¬O§_¥NªíµÛÁ{§ÉÁͦV¥¿¦Vµo®i ? §_«h¾Ì¬Æ»ò¨ì­»´ä¤W¥«¤Þ¸ê ?

¤S«ä¦Ò±¾µP«eªº¤£¥æ©ö´Á , ¬O§_«ê¥i¸ú¹L¬üªÑªº¤£Ã­©w´Á ?

¥B·í±¾µP®É , ­YSND-13¤wªñ¦¨¥\ , ¬Æ©Î¸Ñª¼¦¨¥\

¨º±¾µP»ù©Î±N§ó¦³·Q¹³ªÅ¶¡ ?

«¢ ! ¤ñ°_¥xÆW°h¥X¿³Âdªº»ù®æ , ®M¥yªÑ¥«³N»y --- ©Î¥i¤j´T¸õªÅ¶}°ª ( °²¦p¿³Âd»ù®æ¤´¨S¶i®iªº¸Ü )

§Æ±æ¤ß®®¤½¥qµo®i¶¶§Q¦¨¥\ , ¤]®É®É¥HªÑªFÅv¯q¬°©À , ¬O¬°¦Ü¬ß

¤@´[±¡Ä@²q´úªºÃ¨¤ß¦k·Q , ½Ð¤j®a¬Ý¬Ý´N¦n , ¤Á¤Å·í§ë¸ê¨Ì¾Ú

¨Ã½Ð«ü¾É«ü¥¿

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

·|­û:seniorbbs10144999µoªí®É¶¡:2018/11/29 ¤U¤È 07:52:55²Ä1045½g¦^À³
¤½¥qªº°Ê§@¶V¨Ó¶VÀWÁc¤F,¤½¥q®Ö¤ß¤Hª«½Õ¨ì¨ä¥L¤l¤½¥q¥h.. ¤j®a«ø¥Ø¥H«Ý§a...
·|­û:²q·Q10136148µoªí®É¶¡:2018/11/29 ¤U¤È 06:28:01²Ä1044½g¦^À³
¬Q¤éªº¤½§i

1.¤H­ûÅܰʧO¡]½Ð¿é¤Jµo¨¥¤H¡B¥N²zµo¨¥¤H¡B­«­nÀç¹B¥DºÞ¡B°]°È¥DºÞ¡B

·|­p¥DºÞ¡B¬ãµo¥DºÞ©Î¤º³¡½]®Ö¥DºÞ¡^:µo¨¥¤H¡B¥N²zµo¨¥¤H¡B°ÆÁ`¸g²z¤Î°]·|¥DºÞ

2.µo¥ÍÅܰʤé´Á:107/11/28

3.ÂÂ¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:

µo¨¥¤H/ ½²¥É´@ °]·|³¡¸g²z

¥N²zµo¨¥¤H/ ¶À¼yªÛ ¤H¨Æ¦æ¬F³¡¸ê²`¸g²z

°ÆÁ`¸g²z/ ¤ý´º¥¿ °ÆÁ`¸g²z

°]·|¥DºÞ/ ½²¥É´@ °]·|³¡¸g²z

4.·s¥ôªÌ©m¦W¡B¯Å¾¤Î²¾ú:

µo¨¥¤H/ «¸§Ó¿« °ÆÁ`¸g²z

¥N²zµo¨¥¤H/ ÃC©É¯u ½]®Ö«Ç¸g²z

°]·|¥DºÞ/ ¬ö©{§D °]·|³¡°Æ²z

5.²§°Ê±¡§Î¡]½Ð¿é¤J¡uÃ㾡v¡B¡u¾°È½Õ¾ã¡v¡B¡u¸ê»º¡v¡B¡u°h¥ð¡v¡B¡u¦º¤`¡v©Î¡u·s

¥ô¡v¡^:Ãã¾

6.²§°Ê­ì¦]:

½²¥É´@¸g²zÃã¥ô¥»¤½¥qµo¨¥¤Hº[°]·|¥DºÞ¡AÂà¥ôSyneuRx Neuroscience HK Ltd.¤½¥q¡C

¶À¼yªÛ¸g²zÃã¥ô¥»¤½¥q¥N²zµo¨¥¤H¡AÂà¥ô¤ß¼Ö¥ÍÂ妳­­¤½¥q¡C

¤ý´º¥¿°ÆÁ`¸g²zÃã¥ô¥»¤½¥q°ÆÁ`¸g²z¡AÂà¥ôSyneuRx Neuroscience HK Ltd.¤½¥q¡C

7.¥Í®Ä¤é´Á:107/11/28

8.·s¥ôªÌÁpµ¸¹q¸Ü:02-77422699

9.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¼È¥Ñ¥»¤½¥q°]·|°Æ²z¬ö©{§D¥N²z°]·|¥DºÞ¡A«S³Ìªñ´Á¸³¨Æ·|¨Mij

³q¹L·s¥ô°]·|¥DºÞ¸u¥Î®×«á¦A¦æ¤½§i¡C

·|­û:¤ß®®¨H¯B10142041µoªí®É¶¡:2018/11/29 ¤W¤È 11:42:19²Ä1043½g¦^À³
¨ä¹ê¹L¥h³sÄò¤j¶^¤]¨S¤H°Q½×¡A

¶³¹L¤sÀYı¤Ñ§C ±ýµn®p¤WIJ¥i¤Î

ÂQ©¹¤Ñ¥~µL·³¤ë ¤£­p¤µ´Â¬O´X®É

...²H©wing

·|­û:YOYO10140343µoªí®É¶¡:2018/11/29 ¤W¤È 11:28:31²Ä1042½g¦^À³
Àµ¨DGG¤Î¤p¤á´£ÂI¤@¤U¨ä¤¤¤§¶ø§®
·|­û:¤p¤á10140918µoªí®É¶¡:2018/11/29 ¤W¤È 11:04:40²Ä1041½g¦^À³
¤£»Ý­n¤j¸v«Å´­, ¬Ý±oÀ´ªº¤H´N¤ß¸Ì¦³¼Æ¤F.
·|­û:GG10139724µoªí®É¶¡:2018/11/29 ¤W¤È 10:03:52²Ä1040½g¦^À³
³s¨â¤Ñ¤jº¦¤Î­«¤j°T®§µo¥¬, ³£¨S¤H°Q½×, ¤ß®®ªÑ¤Í¯u¬O²H©w°Ú!
·|­û:²q·Q10136148µoªí®É¶¡:2018/11/25 ¤U¤È 08:27:54²Ä1039½g¦^À³
2018¯«¸g¬ì¾Ç»â°ì¥þ²y¥æ©öÁaÄý¤ÎÁͶÕ

¬ìºÍ°ß¦w¡]Clarivate Analytics¡^ 2018-11-25

­ì¤å§@ªÌ¡GJamie Munro & Helen Dowden

¤¤¤å½Ķ¡GÀxÌɵØ

med.sina.cn/article_detail_103_2_56449.html

³Ìªñ¤­¦~¨Ó¡A¾¨ºÞ¬Û¹ï¨Ó»¡¡A¨u¨£¯f¦p¹B°Ê¯«¸g¤¸¯e¯f¡A¥H¤Î¸£¦åºÞ¯e¯f©M¸£·l¶Ëµ¥¯e¯fªº¥æ©ö¥X²{¤F§ó¤j´T«×ªº¼Wªø¡A¦ý¯kµh©Mªüº¸¯÷®üÀq¯g¬ÛÃöªº¥æ©ö¥¿¦b¼W¥[¡C¦¹¥~¡A¤@¨Ç¨à¬ìºë¯«¯e¯f¡A¦p¦Û³¬¯g©M¹p¯Sºî¦X¼xªº¥æ©ö¬¡°Ê¤]¦³©Ò¼W¥[¡CµM¦Ó¡AÁöµMÅöíw©Mºë¯«¤Àµõ¯g³o¨âºØ¯e¯f¨Ã¨S¦³±o¨ì«Ü¦nªº±±¨î¡A¦ý¬ÛÃöªº¥æ©ö¼Æ¶q¦b³o¬q®É¶¡¸Ì¥X²{¤F©úÅ㪺¤U­°¡]¹Ï1b¡^¡C

¬°¦ó¦b«äı¥¢½Õ»â°ìªñ¦~¨Ó¥æ©ö¼Æ¶q§e²{©úÅã¤U­°¡H

©Î¦]¨S¦³«GÂI·sÃÄ¡H

«äı¥¢½Õ»â°ì¥¿¦V¯gª¬ÃĪ«¤w§e¾ÖÀ½¡A¤j¼t©Î±N¥Ø¥úª`µø¦b­t¦V¯gª¬¤Î»{ª¾³o¨â¶µ¥¼³Qº¡¨¬ªº»â°ì

¥¿¦]¬°¦¹

Åý¤H¹ïSND-11; 12; 13±H¤©«p±æ¡I¡H

§Æ±æ 2b+3 ´ÁÁ{§ÉªºÃĮįà¦p 2a ´Á£¸¼Ë«GÄR¡A¾P°â©Î±N¥i´Á«Ý

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a ¡I

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/23 ¤W¤È 11:57:28²Ä1038½g¦^À³
§Ü§íÆ{ÃĪ«¥«³õ2023¦~±N¹F¨ì159.8»õ¬ü¤¸

¨Ó·½¡G°Ê¯ßºô ¡@2018-11-23

§@ªÌ¡GMailman

med.sina.com/article_detail_103_2_56397.html

ªñ¤é¡AAllied Market Researchµo¥¬¤F¤@½g¦W¬°¡m§íÆ{¯gÃĪ«¥«³õ§íÆ{¯g¡]­«©Ê§íÆ{¯g¡B±j­¢¯g¡B¼sªx©ÊµJ¼{¯g¡B®£·W¯gµ¥¡^©M²£«~¡]¤TÀôÃþ§Ü§íÆ{ÃÄ¡B¿ï¾Ü©Ê5-ßm¦âÓi¦AÄá¨ú§í»s¾¯¡B5-ßm¦âÓi¥h¥ÒµÇ¤W¸¢¯À¦AÄá¨ú§í»s¾¯¡B³æÓi®ñ¤Æ酶§í»s¾¯¡B5-ßm¦âÓi«ú§Ü¾¯©M¦AÄá¨ú§í»s¾¯¤Î¨ä¥L¡^¡G¥þ²y¾÷·|¤ÀªR©M¦æ·~¹w´ú¡A2017-2023¡nªº¤å³¹¡C¤å³¹Åã¥Ü¹w­p¨ì2023¦~¥þ²y§Ü§íÆ{ÃĪ«¥«³õ±N¹F¨ì159.8»õ¬ü¤¸¡A¹w´ú´Á¤º´_¦X¦~¼Wªø²v¬°2.1¢H¡A°Ê¯ßºô¬°±z½sĶ¤F¸Ó¤å³¹ªº¥DÃD¤º®e¡G

¸Ó³ø§i³q¹L¦æ·~ÁͶաBÅX°Ê¦]¯À©M¾÷¹J¡BÃöÁä¼Wªøµ¦²¤¥H¤ÎÄvª§®æ§½¡A¹ï¥þ²y§Ü§íÆ{ÃÄ¥«³õ¶i¦æ²`¤J¤ÀªR¡C®Ú¾Ú¸Ó³ø§i¡A2017¦~¥þ²y§Ü§íÆ{ÃĪ«¥«³õ¬°141.1»õ¬ü¤¸¡A¹w­p¨ì2023¦~±N¹F¨ì159.8»õ¬ü¤¸¡A¹w´ú´Á¤º´_¦X¦~¼Wªø²v¬°2.1¢H¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/23 ¤W¤È 10:26:43²Ä1037½g¦^À³
SAGE-217 ¬O brexanolone(SAGE-547)ªº¤fªA¾¯«¬

¬JµM brexanolone ¦³ ÀH³X´Á¶¡ªº¦Û±þ·N©À

¬O§_¤]¥NªíµÛ SAGE-217 ¤]¦³³oºØ°Æ§@¥Î ?

¤j®a¦³½Öª¾¹D¶Ü?

½Ð¤£§[¤À¨É

ÁÂÁ¤j®a!

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/23 ¤W¤È 10:17:15²Ä1036½g¦^À³
FDA©µ¿ð§å­ã²£«á§íÆ{·sÃÄbrexanolone¤W¥«­n¨D¸É¥æ­·ÀIµû¦ô

¨Ó·½¡GÂåÃÄÅ]¤è ¡@2018-11-23

§@ªÌ¡G«C¥Ë

med.sina.com/article_detail_103_2_56378.html

¦b¬ü°ê¡AFDA¤w±Â¤©brexanoloneªvÀø²£«á§íÆ{ªº¬ð¯}©ÊÃĪ«¸ê®æ¡A¦b¼Ú·ù¡AEMA¤]¤w±Â¤©Àu¥ýÃĪ«¸ê®æ¡]PRIME¡^¡C

¥u¬O¸ÓÃĪ«ªº¨Ï¥Îµ¹¤©60¤p®ÉÀR¯ß¿éª`ªº±wªÌ¡A­n¨D±wªÌ©M´£¨ÑªÌ©Ó¿Õªø´ÁªºÁ{§É¿éª`¡C

Brexanolone¬O¬ðIJ©M¬ðIJ¥~£^-®ò°ò¤B»ÄA «¬¨üÅé¡]GABAA ¨üÅé¡^ªºÅܺc½Õ¸`¾¯¡CGABAA¨üÅé©MNMDA¡]N-methyl-D-aspartate¡^¨üÅé¤À§O°_¨ì§í¨î©M¨ë¿E¤j¸£¯«¸g¤¸²£¥Í¯«¸g½Ä°Êªº§@¥Î¡C³o¨âºØ¨üÅ鬡©Ê¤§¶¡ªº¥¢¿Å¬O¥]¬A§íÆ{¯g¦b¤ºªº¦hºØºë¯«¯e¯fªº­ì¦]¡C

³Ì±`¨£ªºbrexanoloneªvÀø¬ÛÃö¤£¨}¨Æ¥ó¬°ÀYµh¡BÀY©ü¡B¶ÝºÎ¡Aµo¥Í4¨ÒªvÀø¬ÛÃöªºÄY­«¤£¨}¨Æ¥ó¡A¥]¬AÀH³X´Á¶¡¦Û±þ·N©À¡B¬G·NÃĪ«¹L¶q¡B·NÃѪ¬ºA§ïÅÜ»P·w³Ö¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/12 ¤W¤È 11:19:30²Ä1035½g¦^À³
·sª¾¦@½à

¥þ²y³Ì¤ûMRI¡I¥i¬Ý¨ì¤j¸£©Ò¦³²Ó¸`

¨Ó·½¡GÁɬfž¹±ñ ¡@2018-11-12

¨Ó·½¡Gºî¦X¦ÛNature©xºô¡BÂå¾Ç¬É¾ã²z¡GÁɬfž¹±ñ

med.sina.com/article_detail_103_1_55679.html

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/11 ¤U¤È 07:00:52²Ä1034½g¦^À³
2018¥Íª«ÂåÃĦæ·~¶W»õ¬ü¤¸¬ãµo¤j¦X§@¦³¦h¤Ö¡H

¨Ó·½¡G³ÐŲ¶× ¡@2018-11-11

med.sina.com/article_detail_108_1_55659.html

¨ä¤¤¦³Ãöºë¯«¯«¸g»â°ìªº¦³:

¤½¥q¦WºÙ¡GDenali Therapeutics»PTakeda

¥æ©öª÷ÃB¡G10»õ¬ü¤¸

¦X§@»â°ì¡G¯«¸g°h¦æ©Ê¯e​​¯f

¤½¥q¦WºÙ¡GIndivior»PAddex Therapeutics

¥æ©öª÷ÃB¡G3.3»õ¬ü¤¸

¦X§@»â°ì¡GÃĪ«¦¨Å}

¤½¥q¦WºÙ¡GKineta»Pù¤ó¶°¹Î¡]Roche Group¡^¦¨­û°ò¦]®õ§J¡]Genentech¡^

¥æ©öª÷ÃB¡G3.6»õ¬ü¤¸

¦X§@»â°ì¡G«Dªü¤ùÃþ¤î¯kÃÄ

¤½¥q¦WºÙ¡G¦Ê°·¡]Biogen¡^¤½¥q©MIonis Pharmaceuticals

¥æ©öª÷ÃB¡G10»õ¬ü¤¸

¦X§@»â°ì¡G¯«¸g¯e¯f·sÃÄ

¤½¥q¦WºÙ¡GSage Therapeutics»PÆQ³¥¸q»sÃÄ¡]Shionogi¡^

¥æ©öª÷ÃB¡G5.75»õ¬ü¤¸

¦X§@»â°ì¡G§Ü§íÆ{ÃÄ

¤½¥q¦WºÙ¡GDenali Therapeutics»PÁÉ¿Õµá¡]Sanofi¡^

¥æ©öª÷ÃB¡G10»õ¬ü¤¸

¦X§@»â°ì¡G¯«¸g¨t²Î¯e¯f·sÃÄ

¸Ô±¡½Ð°Ñ­ì¤å³sµ²

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

·|­û:´M³V10132258µoªí®É¶¡:2018/11/8 ¤U¤È 03:50:42²Ä1033½g¦^À³
mops.twse.com.tw/mops/web/query6_1

¤º³¡¤H«ùªÑ²§°Ê¨Æ«á¥Ó³øªí

¤w¸g¦³¤½§i¤F~§Æ±æ¤½¥q¦n®ø®§¶V¨Ó¶V¦h~

·|­û:seniorbbs10144999µoªí®É¶¡:2018/11/8 ¤U¤È 03:25:18²Ä1032½g¦^À³
¦n¼F®`¡A¤½¶}¸ê°TÆ[´ú¯¸³£ÁÙ¨S¦³¤½¥¬¡A©¯¹B¤j´Nª¾¹D¤F....
·|­û:¤p©¯¹B10141538µoªí®É¶¡:2018/11/8 ¤U¤È 02:44:33²Ä1031½g¦^À³
°ò¥»­±¶V¨Ó¶V¦n..¤½¥q»ù­È³QÄY­«§C¦ô...

¤½¥q¤jªÑªF«ùÄò¼W¥[«ùªÑ...

¤º³¡¤HÃö«Y¤H«ùªÑ¥Ñ620±i..10¤ë©³¸ê®Æ¼W¥[¦Ü930±i...

°]°È³¡ªù¥DºÞ10¤ë©³«ùªÑ¥Ó³ø¼W¥[23±i...

¥H¤W~¨Ñµ½¨}.´¼¼z¤§ªø½u§ë¸ê¾Ô¤Í­Ì°Ñ¦Ò~~

·|­û:YOYO10140343µoªí®É¶¡:2018/11/8 ¤W¤È 09:42:35²Ä1030½g¦^À³
11/7¤é¤½§iªº§Q¦hÀ³¥u¬O¤pµæ¦Ó¤w,¹Ú¨ì¤½¥qÁÙ¦³¤@¨Ç¤jµæ¦b«á­±,¤½¥q§V¤O³o»ò¤[¤F,·U¨ì«á­±ªG¹ê§Ö¥i¥H¦¬¦¨®É,没¦³§â¥¦½æ±¼ªº²z¥Ñ,¥u­n³{§C¥[½Xªº°Ê¤O,°²³]¥¼¨Ó²{¼W»ù100¤¸(·í®É¥«»ù120),³o­Ó»ù¦ì«ç»ò¶RÀ³¸Ó³£¬O¦n»ù®æ§a
·|­û:²q·Q10136148µoªí®É¶¡:2018/11/7 ¤W¤È 08:58:08²Ä1029½g¦^À³
Genet ¹ï ­èÀòÃÄÃÒSAGE-547 ªºµû½×

www.genetinfo.com/investment/featured/item/21113.html?start=1

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/6 ¤U¤È 09:15:30²Ä1028½g¦^À³
Alkermes­««×§íÆ{¯g·sÃÄALKS5461¾DFDA©e­û·|§_¨M

¨Ó·½¡G ¥Íª«¨¦ ¡@2018-11-06

med.sina.com/article_detail_103_1_55369.html

ALKS5461¬O¤@ºØ¨C¤é¤@¦¸ªº¤fªAÃĪ«¡A¦®¦b­«·s¥­¿Å§íÆ{¯g±wªÌ¤j¸£ªº¥\¯à¥¢½Õ¡A¸ÓÃĨ㦳¤@ºØ·s¿oªº§@¥Î¾÷¨î¡A¦pªGÀò§å¡A±N¦¨¬°·s¤@Ãþªº§Ü§íÆ{ÃĪ«¡A§Y¤j¸£¤º·½©Êªü¤ù¨t²Î½Õ»s¾¯¡C¤j¸£ªü¤ù¨t²Î¬O¤HÃþ±¡·P©M±¡ºüªº¤@­ÓÃöÁä½Õ¸`¨t²Î¡C¥Ø«e¡AALKS5461¥¿¶}µo§@¬°¤@ºØ»²§UªvÀøÃĪ«¡A¥Î©ó¹ï¼Ð·Çªº§Ü§íÆ{Àøªk¤ÏÀ³¤£¨¬ªº­««×§íÆ{¯g¡]MDD¡^±wªÌ¡C

ALKS5461¥Ñ©T©w¾¯¶qªº¤B¤þ¿Õ°Ø©Msamidorphan¡]ALKS-33¡^²Õ¦¨¡A¨ä¤¤¤B¤þ¿Õ°Ø¬O¤@ºØ£g-ªü¤ù¨üÅ鳡¤À¿E°Ê¾¯©M¥\¯à©Êk-ªü¤ù¨üÅé«ú§Ü¾¯¡A¨ã¦³¦¨Å}­·ÀI

Alkermes¤½¥q¤§«e¹w­p¡A¦pªG¦¨¥\Àò§å¤W¥«¡AALKS5461¦³±æ¦¨¬°¤@´Ú­«½SÃĪ«¡C¤µ¦~2¤ëµo¥¬ªº2017°]¦~³ø§i¤¤¡A¸Ó¤½¥qªí¥Ü¡A¹w­pFDA¦b¨ü²zNDA¤§«á·|¥[³t¼f¬d¡A¨Ã¦b¤µ¦~¤U¥b¦~§å­ãALKS5461¡C¤£¹L¡A±q¥Ø«e±¡ªp¨Ó¬Ý¡A¸Ó¤½¥qªº­«½S´Á±æ«Ü¦³¥i¯à­n¸¨ªÅ¤F¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/6 ¤W¤È 11:06:17²Ä1027½g¦^À³
SAGE ´¿Àò BTDªº²£«á§íÆ{¯g·sÃÄZulresso¡]brexanolone¡^ÀòFDA§å­ã¤W¥«

¨Ó·½¡GÃÄ©ú±d¼w¡@

2018-11-06

med.sina.com/article_detail_100_2_55332.html

¤é«e¡ASage Therapeutics¤½¥q«Å¥¬¡AFDA¿Ô¸ß©e­û·|¥H17:1ªº§ë²¼µ²ªG¡A±ÀÂËFDA§å­ã¸Ó¤½¥q¬ãµoªº¥Î©óªvÀø²£«á§íÆ{¯g¡]PPD¡^ªºZulresso¡]brexanolone¡^¤W¥«¡C¦pªGÀò±o§å­ã¡A³o±N¬O²Ä¤@´Ú°w¹ïPPDªºÀò§åÃĪ«¡C

Zulresso¬OSage¤½¥q¬ãµoªº¤@ºØGABA-A¨üÅéÅܺc½Õ¸`¾¯¡C¹ï¯«¸g»¼½è¨üÅ骺Åܺc½Õ¸`¯à°÷±N¨üÅ鬡©Ê½Õ¸`¨ì¤£¦Pªº¤ô¥­¡A¦Ó¤£¬O§¹¥þ¿E¬¡©ÎªÌ§í¨î³o¨Ç¨üÅé¡CZulresso¤w¸gÀò±o¤FFDAªº¬ð¯}©ÊÀøªk»{©w©M¼Ú¬wÃÄ«~ºÞ²z§½ªºPRIMEÃÄ«~»{©w¡C

FDA¦b¤µ¦~5¤ë30¤é±µ¨ü¤FZulressoªº·sÃĥӽС]NDA¡^¨Ã¥B±Â¤©¨äÀu¥ý¼fµû¸ê®æ¡C³o·N¨ýµÛ¸ÓÃĪ«¦³±æ¦b¤µ¦~12¤ë19¤é¥H«eÀò±o§å­ã¡A¬°¨ü¨ìPPD§xÂZªº¶ý¶ý­ÌÄm¤W¤@¥÷¸t½Ï§ª«¡C

·|­û:²q·Q10136148µoªí®É¶¡:2018/11/2 ¤W¤È 10:12:30²Ä1026½g¦^À³
Denali»PÁÉ¿Õµá¹F¦¨¶W10»õ¬ü¤¸¦X§@

¨Ó·½¡GÃÄ©ú±d¼w¡@2018-11-02

med.sina.com/article_detail_100_2_55180.html

¤µ¤é¡A±Mª`©ó¶}µoªvÀø¯«¸g°h¦æ©Ê¯e​​¯fÃĪ«ªº¥Íª«ÂåÃĤ½¥qDenali Therapeutics«Å¥¬±N»PÁÉ¿Õµá¡]Sanofi¡^¦X§@¶}µo¦hºØRIPK1¡]¨üÅé¬Û¤¬§@¥Îµ·®ò»Ä/Ĭ®ò»Ä-³J¥Õ¿E酶1¡^§í»s¾¯¤À¤l¡A¥Î©óªvÀø¤@¨t¦C¯«¸g¨t²Î¯e¯f©M¥þ¨­ª¢¯g©Ê¯e¯f¡C

¨ä¤¤¨âºØ­Ô¿ï¤À¤lDNL747©MDNL758¦®¦b¹v¦VTNF¨üÅé³q¸ô¤¤ªºÃöÁä«H¸¹³J¥ÕRIPK1¡A³oºØ³J¥Õ¯à½Õ¸`¥þ¨­²Õ´¤¤ªºª¢¯g©M²Ó­M¦º¤`¡C¦X§@Âù¤è­p¹º¬ã¨sDNL747ªvÀøªü¯÷®üÀq¯f¡B¦ÙµäÁY°¼¯Áµw¤Æ¯g¡]ALS¡^©M¦hµo©Êµw¤Æ¯g¡]MS¡^ªº®ÄªG¡A¥H¤ÎDNL758ªvÀø¥þ¨­ª¢¯g©Ê¯e¯f¡]¨Ò¦pÃþ­·Àã©ÊÃö¸`ª¢©M»È®h¯f¡^ªº®ÄªG¡C

®Ú¾Ú¨óij±ø´Ú¡AÁÉ¿Õµá±N¦VDenali¤ä¥I1.25»õ¬ü¤¸ªº¹w¥I´Ú¡A¥H¤Î¥¼¨Ó¥i¯à¶W¹L10»õ¬ü¤¸ªº¶}µo©M±À¼s¨½µ{¸O¥I´Ú¡CÁÉ¿Õµá©MDenali±N¦@¨ÉDNL747¦b¬ü°ê©M¤¤°ê±À¼sªº¦¬¯q©M­·ÀI¡A¦ÓDenali±NÀò±oDNL747¦b¨ä¥L¦a°Ï©MDNL758¦b¥þ²yªº¾P°â¤À¦¨¡C

·|­û:¤j¤á¤H®a10140174µoªí®É¶¡:2018/10/31 ¤W¤È 11:35:35²Ä1025½g¦^À³
§Ö¨ì¦~©³¤F, ¸êª÷²z½×¤WÀ³¸Ó¤]¿N¤F®t¤£¦h¤F, ¦¬®×³t«×¦]¬°¬D¿ï¯f¤H¦n¹³¤]µLªk¤Ó§Ö, ²{¦b¥Í§Þ·~ªº¶Ò¸ê§x¹Ò, ¹ï¤½¥q¸gÀç¤WÀ³¸Ó¬O¤@¤j¦ÒÅç¤F.
·|­û:booli10146418µoªí®É¶¡:2018/10/31 ¤W¤È 10:09:00²Ä1024½g¦^À³
´Á¤¤¤ÀªR¥u¬O¬°¤F½Õ¾ã¤H¼Æ¨Ã¨S¦³³]­p¸Ñª¼¡A¤£­n¦³¿ù»~ªº¹w´Á

§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:¤ß®®¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!